Repeat Influenza Vaccination Effects in 2021/22 and 2022/23 in a Community-Based Cohort in Hong Kong - Summary - MDSpire

Repeat Influenza Vaccination Effects in 2021/22 and 2022/23 in a Community-Based Cohort in Hong Kong

  • By

  • Jennifer C Zhong

  • Shuyi Zhong

  • Lisa Touyon

  • Faith Ho

  • Niki Y M Au

  • Samuel M S Cheng

  • Dennis K M Ip

  • Malik Peiris

  • Emily T Martin

  • Sarah Cobey

  • Sook-San Wong

  • Nancy H L Leung

  • Benjamin J Cowling

  • January 28, 2026

  • 0 min

Share

Objective:

To investigate the impact of repeated annual influenza vaccination on antibody titer boosting and waning rates in a Hong Kong community cohort, highlighting its significance for public health.

Key Findings:
  • Repeat vaccination was associated with reduced titer increase at day 14 post-vaccination, suggesting implications for vaccination strategies.
  • Participants with higher vaccination uptake showed slower antibody waning against specific strains, indicating potential benefits of consistent vaccination.
  • Post-vaccination antibody titers at 6 months were similar across different vaccination histories, raising questions about long-term immunity.
Interpretation:

Repeated influenza vaccination may lead to diminished immediate antibody responses, which could influence public health recommendations, but does not significantly affect long-term antibody levels.

Limitations:
  • Study conducted during a period with no influenza circulation, limiting generalizability.
  • Focus on specific strains may not represent overall vaccine effectiveness.
  • Potential biases in participant selection or reporting could affect results.
Conclusion:

Annual influenza vaccination impacts short-term immune response but has less effect on long-term antibody levels, emphasizing the need for ongoing evaluation of vaccination strategies.

Original Source(s)

Related Content